ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,516.00
      1.01%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      -2.20%
      Bitcoin
      67,900.17
      3.21%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Amicus Therapeutics Inc (FOLD)

      7. Amicus Therapeutics Inc (FOLD) Financials

      Amicus Therapeutics Inc

      Amicus Therapeutics Inc (FOLD)

      NASDAQ
      10.18
      -0.08
      (-0.78%)
      At close: July 26 4:00PM
      Delayed by 15 minutes
      10.18
      0.01
      ( 0.10% )
      After Hours: 4:25PM
      Delayed by 15 minutes

      Amicus Therapeutics Inc Financial Summary

      The current FOLD market cap is 3.02B. The company's latest EPS is USD -0.5118 and P/E is -19.87.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 86.27M94.5M103.5M115.08M110.4M
      Operating Income -37.64M-17.39M-15.03M-3.69M-27.72M
      Net Income -52.93M-43.23M-21.58M-33.84M-48.42M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 182.24M260.89M305.51M329.23M399.36M
      Operating Income -304.04M-247M-206.43M-204.43M-73.49M
      Net Income -356.39M-276.85M-250.46M-236.57M-151.58M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 700.52M730.09M764.08M777.88M721.79M
      Total Liabilities 597.95M618.51M630.85M617.71M591.1M
      Total Equity 102.57M111.58M133.24M160.17M130.69M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 850.21M886.52M905.14M724.17M777.88M
      Total Liabilities 373.78M600.14M597.77M601.12M617.71M
      Total Equity 476.43M286.38M307.37M123.05M160.17M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -18.07M-34.2M-72.55M-69.09M-29.7M
      Investing 36.26M86.26M122.02M98.06M7.54M
      Financing -7.83M15.85M53.47M61.68M-13.31M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -250.42M-233.29M-202.49M-166.58M-69.09M
      Investing 95.15M-13.58M78.76M92.32M98.06M
      Financing 217.5M262.86M212.07M-7.46M61.68M

      Stats and Ratios

      Market Cap 3.02B
      Price to Earnings Ratio -19.87
      Price to Sales Ratio 7.54
      Price to Cash Ratio 12.2
      Price to Book Ratio 18.81
      Dividend Yield -

      Share Statistics

      Shares Outstanding 296.2M
      Average Volume (1 week) 3.67M
      Average Volume (1 Month) 2.31M
      52 Week Change -23.63%
      52 Week High 14.57
      52 Week Low 9.02
      Spread (Intraday) 1.96 (17.64%)

      Company Info

      Company Name Amicus Therapeutics Inc
      Address 1209 orange street
      wilmington, delaware 19801
      Website https://www.amicusrx.com
      Industry pharmaceutical preparations (2834)